|
The website domain reflects its role for my own purpose only. Viewing of the webpages by others is not approved.
|
|
--- |
Cardiomyopathy and Myocarditis
|
Hypertrophic Cardiomyopathy- ESC 2008Genetic Testing Prevalence 1:500 on echo. 60% of these will have sarcomeric mutations. note it is not uncommon to have two mutations in the same family. Double hits are present in about 5% of probands- need to take cae with counselling and be careful to assess for all known mutations. May find a variance in a gene but this does not definitely mean that this is disease causing. Note with HCM mostly dealing with missense or nonsense mutations, when screening
Imaging About 70% have assymmetric hypertrophy and remaining have concentric or apical hypertrophy. Septal hypertrophy patterns
Risk stratification Desai from Cleveland Clinic- see articles HCM and pacing AV synchronous pacing can be effective in some with LVOT obstruction by inducing dyssynchrony. But of note is that there are only three crossover randomised trials- all three found improvement of symptoms with pacing, but in 2/3 there was no objective improvement in terms of exercise time. Pacing may well be most effective in those with a sigmoid shaped LV and not those with severe concentric LVH. These are also the same group that do not respond well to myectomy. Clearly should not consider asymptomatic patients with no gradient. HCM and surgery- still the gold standard Reference- JACC 2004;44:2329-32 (have this article) Alcohol septal ablation leads to RBBB in 30-60% of cases and risk of CHB. With myectomy tend to get LBBB. |